A Clinical Trial to Evaluate the Efficacy and Safety of Choline Alfoscerate in Vascular Cognitive Impairment Patients

NCT05050604 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

418

Enrollment

INDUSTRY

Sponsor class

Conditions

Vascular Cognitive Impairment

Interventions

DRUG: Choline Alfoscerate 400mg
DRUG: Placebo of Choline Alfoscerate 400mg

Sponsor

Chong Kun Dang Pharmaceutical

Collaborators

[object Object]